Portfolio Welcome: Hilltop Bio

We are pleased to welcome Hilltop Bio to the RevUp portfolio!

This Boston-based veterinary biotech company offers a suite of regenerative therapies focused on helping four-legged animals reduce inflammation and heal from injuries or disease. 

When founder and CEO Amanda Drobnis–a lifelong horse rider–suffered a serious hip injury at the age of 29, her doctors gave her two options: a full hip replacement or an experimental treatment. Curious about the latest advancements in regenerative medicine, Amanda chose to experiment. Within a few weeks of treatment she was back on her feet and back in the saddle. 

After experiencing the benefits of regenerative therapy herself, Amanda set forth to use the same technology to develop products for animals. Today, Hilltop Bio sells a portfolio of products to veterinary practices across the country. The company is expanding with the release of new products and expansion from the equine market into the companion animals / canine market. 

As investors–and as animal lovers–we are excited to welcome Amanda and the Hilltop team to the RevUp family!

More About RevUp Capital

RevUp Capital invests in B2B and B2C companies that are revenue-driven and ready to double down on growth. We deploy cash and capacity to help companies grow from $1-3M to $10-30M, quickly and efficiently, using a revenue-based model. Companies enter our portfolio with $500K-$3M in revenue, a strong growth rate, and a team that’s ready to scale. Our typical investment range is $300K-$500K.

We invest into a company's market-facing activity using a cash and capacity model. We pair our cash investment with dedicated support from the RevUp Growth Platform: a powerful resource to build a data-driven growth engine, delivered by people who get the work done. Rather than take equity, companies return investment through a small percentage of revenue over time. More at www.revupfund.com